We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current LNTH market cap is 5.61B. The company's latest EPS is USD 4.7670 and P/E is 17.17.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 300.78M | 321.7M | 319.95M | 354M | 369.98M |
| Operating Income | -9.34M | 124.14M | 112.36M | 137.49M | 100.38M |
| Net Income | -2.81M | 94.13M | 131.96M | 103.38M | 131.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 347.34M | 339.41M | 425.21M | 935.06M | 1.3B |
| Operating Income | 51.66M | -4.2M | -76.09M | 36.2M | 364.64M |
| Net Income | 31.67M | -13.47M | -71.28M | 28.07M | 326.66M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.35B | 1.34B | 1.52B | 1.65B | 1.83B |
| Total Liabilities | 903.77M | 785.08M | 822.85M | 835.26M | 885.79M |
| Total Equity | 445.52M | 552.65M | 698.76M | 815.89M | 945.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 405.92M | 869.82M | 863.78M | 1.32B | 1.65B |
| Total Liabilities | 291.32M | 355.62M | 399.35M | 874.11M | 835.26M |
| Total Equity | 114.6M | 514.21M | 464.44M | 447.15M | 815.89M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 108.5M | 76.23M | 192.97M | 305.26M | 127.24M |
| Investing | -44.51M | -65.21M | 18.01M | 5.94M | -106.53M |
| Financing | -8.67M | -12.72M | -12.61M | -13.06M | -16.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 80.38M | 16.4M | 53.92M | 281.78M | 305.26M |
| Investing | -22.06M | -4.91M | 3.68M | -276.55M | 5.94M |
| Financing | -78.88M | -21.86M | -39.33M | 311.69M | -13.06M |
| Market Cap | 5.61B |
| Price to Earnings Ratio | 17.17 |
| Price to Sales Ratio | 4.33 |
| Price to Cash Ratio | 7.86 |
| Price to Book Ratio | 6.87 |
| Dividend Yield | - |
| Shares Outstanding | 68.53M |
| Average Volume (1 week) | 688.98k |
| Average Volume (1 Month) | 852.6k |
| 52 Week Change | -6.03% |
| 52 Week High | 94.47 |
| 52 Week Low | 50.20 |
| Spread (Intraday) | 5.64 (6.78%) |
| Company Name | Lantheus Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.lantheus.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
